Insights

We’re only just smoothing the surface of consumer skincare product personalisation. The current trend for products to be curated, customised or even bespoke to some degree, is simply the start. 

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

The next step in the fight against coronavirus looks set to be mass screening of whole cities and towns. Symon Cotton, Head of Life Sciences at Cambridge Consultants, believes that so-called multipool screening could make all the difference to the success of this approach during the current second wave of the virus.

Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.  

In September the UK government announced Operation Moonshot – to deliver the mass screening of 10 million samples for COVID-19 every day. Andrew Goulter takes a pragmatic look at five key areas of focus if we are to increase screening efficiency and capacity. 

“You mean you just want me to throw all that packaging away? There’s enough waste here to fill three trash cans!” The fact that we repeatedly get feedback like this during patient interviews these days highlights just how important the environmental impact of a product has become.

With fewer than 100 days of the Brexit transition period remaining, it’s clear that medical device manufacturers will need to respond efficiently to the new regulatory developments. Sara Dodd looks at the unfolding new regulatory landscape.

Despite intense media focus and impassioned societal debate, meaningful progress on climate change is a glacially slow business - this is particularly true in the medical device sector. Dan Cowen explores how radical technological innovation is the way forward.

James Hallinan's takeaway from SynBioBeta 2020: Synbio is growing up and getting ever more relevant to the everyday. 

The UK biotechnology scene is buzzing with debate right now, with critical themes like green growth and sustainability really coming to the fore. The pandemic has thrust science and scientists into the spotlight like never before – and each of us has a responsibility to contribute to the sort of response that will help create a more resilient world.  

It could only happen at Cambridge Consultants. An internal training course for a group for engineers eager to gain some understanding of how it is possible to engineer biology. A challenge certainly… but also indicative of the unique blend of biology, engineering and advanced computation that is enabling our breakthrough work in bioinnovation.

Tim Ensor shared his insights from working with a global medical device company to invent deep learning algorithms to amplify clinical trials data by 30x.